Evidence map›Paper›PMID 32308369›Full record

ArticleDrug design, development and therapy2020

One-Pot Synthesis of Novel Thiazoles as Potential Anti-Cancer Agents.

Abdelwahed R Sayed, Sobhi M Gomha, Eman A Taher, Zeinab A Muhammad, Hesham R El-Seedi, Hatem M Gaber, Mahgoub M Ahmed

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Exploring the Therapeutic Potential of 1,3-Thiazole: A Decade Overview.Medicinal chemistry (Shariqah (United Arab Emirates)) · 2025
    Review
  5. Article
  6. Review
  7. Design, Synthesis, andACS omega · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Abdelwahed R SayedDepartment of Chemistry, Faculty of Science, KFU, Hofuf, Saudi Arabia.
Sobhi M GomhaDepartment of Chemistry, Faculty of Science, Cairo University, Giza 12613, Egypt.
Eman A TaherDepartment of Pharmaceutical Chemistry, National Organization for Drug Control and Research (NODCAR), Giza 12311, Egypt.ORCID 0000-0003-0651-8647
Zeinab A MuhammadDepartment of Pharmaceutical Chemistry, National Organization for Drug Control and Research (NODCAR), Giza 12311, Egypt.
Hesham R El-SeediChemistry Department, Faculty of Science, El-Menoufia University, Shebin El-Kom 32512, Egypt.
Hatem M GaberDepartment of Pharmaceutical Chemistry, National Organization for Drug Control and Research (NODCAR), Giza 12311, Egypt.ORCID 0000-0001-6210-628X
Mahgoub M AhmedMolecular Drug Evaluation Department, National Organization for Drug Control and Research (NODCAR), Giza 12311, Egypt.ORCID 0000-0001-8452-8651
National Organization for Drug Control and Research · EGBeni-Suef University · EGCairo University · EGUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThiazole and thiosemicarbazone derivatives are known to have potential anticancer activity with a mechanism of action related to inhibition of matrix metallo-proteinases, kinases and anti-apoptotic BCL2 family proteins. MATERIALS AND

methodsA novel three series of 5-(1-(2-(thiazol-2-yl)hydrazono)ethyl)thiazole derivatives were prepared in a one-pot three-component reaction using 2-(2-benzylidene hydrazinyl)-4-methylthiazole as a starting precursor. MS, IR,

resultsThe results indicated that compounds

conclusionThiazole scaffolds

Indexed as

Antineoplastic AgentsApoptosisCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorHCT116 CellsHep G2 CellsHT29 CellsHumansMolecular StructureStructure-Activity RelationshipThiazolesAntineoplastic AgentsThiazolescyclizationharmineHCT-116HepG2HT-29hydrazoneshydrazonoyl halides

Identifiers

PMID32308369
PMCPMC7138620
OpenAlexW3014685272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.